AKRX up +2.53% percent Today $AKRX High is at 38.91 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
AKRX up +2.53% percent Today $AKRX High is at 38.91 and the Low 37.72 with current volume of 155,850.

Recent News posted below.

Akorn Inc AKRX other info.
http://investorshangout.com/Akorn-AKRX-53272/

AKRX Akorn Inc Recent Headline News

Earnings Look Back: Akorn Is Up 0.9% Since Reporting Quarterly Results 1 Week Ago (AKRX)
Comtex SmarTrend(R) - Mon Nov 17, 4:05PM CST
When Akorn (NASDAQ:AKRX) reported earnings 11 days ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.25 on sales of $155.3 million. The company actually reported EPS of $0.27 on sales of $132.7 million, beating EPS estimates by $0.02 and missing revenue estimates by $22.5 million. Since the company's report, shares of Akorn have risen from $37.88 to $38.21, representing a gain of 0.9% in the past 11 days.
AKRX: 38.27 (+0.38)

AxoGen (AXGN) Looks Good: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:46AM CST
AxoGen (AXGN) was a big mover last session, with shares rising nearly 6% on the day.
IPXL: 29.48 (+0.77), AXGN: 2.70 (+0.06), AKRX: 38.27 (+0.38), MYL: 56.10 (+0.97)

Medical Stocks Tumble But Most Of IBD 50 Trading Well
at Investor's Business Daily - Fri Nov 14, 5:47PM CST
A few medical leading stocks have slid, but otherwise the IBD 50 remained in good shape last week. Illumina (ILMN) and Akorn (AKRX) have fallen below their buy points, while Alexion Pharmaceuticals (ALXN) and Celgene (CELG) exhibited some weakness of...
AKRX: 38.27 (+0.38), ALXN: 192.34 (+5.56), FFIV: 128.18 (+0.32), ILMN: 191.41 (+8.50), SPR: 41.92 (+0.85), AAPL: 115.45 (+1.46), ATHM: 41.82 (-1.03), BITA: 93.78 (+4.40), CELG: 106.94 (+2.58)

SmarTrend Watching for Potential Pullback in Shares of Akorn After 1.41% Gain
Comtex SmarTrend(R) - Fri Nov 14, 4:54PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.90 to a high of $38.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $37.85 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 38.27 (+0.38)

Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:40PM CST
Synageva BioPharma Corp. (GEVA) announced the presentation of new data from a phase III study on sebelipase alfa for LAL deficiency.
GEVA: 76.20 (-0.86), AKRX: 38.27 (+0.38), ADHD: 3.24 (-0.21), CELG: 106.94 (+2.58)

Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 89.33 (+0.90), KBIO: 1.99 (unch), AKRX: 38.27 (+0.38), MYL: 56.10 (+0.97)

Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Fri Nov 14, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $37.68 on volume of 3.0 million shares, above average daily volume of 1.7 million. Akorn (NASDAQ:AKRX) has potential upside of 9.0% based on a current price of $37.68 and analysts' consensus price target of $41.08. Akorn shares should encounter resistance at the 50-day moving average (MA) of $38.00 and support at its 200-day MA of $30.77.
AKRX: 38.27 (+0.38)

Stocks Rally Back After Midday Sell-Off
at Investor's Business Daily - Thu Nov 13, 12:17PM CST
Stocks were trying to recover after a midday sell-off lopped off most of the morning gains. The Nasdaq rose 0.3%, the S&P 500 was flat and the Dow Jones industrial average was up 0.2%. Volume was running at a higher pace than at the same time...
DDS: 109.22 (-0.60), AKRX: 38.27 (+0.38), WMT: 83.78 (+0.21), THRM: 40.64 (+0.86)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 86.02 (+0.32), AKRX: 38.27 (+0.38), WPC: 66.56 (+0.51), FLWS: 8.61 (-0.03), MMSI: 14.87 (+0.01)

Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 52.70 (+3.92), AKRX: 38.27 (+0.38), AEO: 13.26 (-0.08), M: 61.38 (-0.23), FANG: 64.30 (+0.58)

Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.27 (+0.38)

Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 38.27 (+0.38)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.35 (+0.35), LCI: 47.26 (+0.62), AKRX: 38.27 (+0.38), AFSI: 52.90 (+0.29), EXPE: 87.92 (+0.98), FFIV: 128.18 (+0.32), SLXP: 104.05 (+2.84), MPWR: 46.41 (+1.43), TMH: 55.06 (+0.23), ATHM: 41.82 (-1.03)

Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 108.77 (-1.30), ANET: 76.83 (+0.13), AKRX: 38.27 (+0.38), ATHM: 41.82 (-1.03)

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 36.35 (+0.35), HD: 96.62 (-1.41), AKRX: 38.27 (+0.38), ILMN: 191.41 (+8.50)

SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.27 (+0.38)

Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 85.18 (+3.68), SWIR: 39.92 (+1.27), AAP: 146.09 (+0.26), AKRX: 38.27 (+0.38), BABA: 111.66 (-2.59)

Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST

AKRX: 38.27 (+0.38)

Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 38.27 (+0.38)

Akorn Inc. (AKRXQ) Stock Research Links

AKRXQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading